EKF Diagnostics revenues, gross profits fall as expected
20th Mar 2024 12:04
(Sharecast News) - EKF Diagnostics reported revenue of £52.6m in its final results on Wednesday, aligning with market projections, although lower than the prior year's figure of £66.6m.
Read moreDirector dealings: EKF Diagnostics director raises stake
11th Jan 2024 15:11
(Sharecast News) - EKF Diagnostics revealed on Thursday that non-executive director Christopher Mills had acquired 100,000 shares in the AIM-listed global diagnostics business.
Read moreEKF Diagnostics cuts guidance after installation delays
12th Sep 2023 09:13
(Sharecast News) - Shares in EKF Diagnostics fell on Tuesday morning after the medical diagnostic products manufacturer warned that increasing its fermentation capacity is taking longer than planned, and will result in a slower-than-expected acceleration in revenue growth over the medium term.
Read moreEKF completes factory acceptance testing for huge new fermenter
20th Jun 2023 15:24
(Sharecast News) - EKF Diagnostics announced the successful completion of factory acceptance testing for its life sciences division's latest addition on Tuesday - a 14,500-litre enzyme fermenter.
Read moreEKF Diagnostics trading well as it progresses fermentation investment
17th May 2023 15:46
(Sharecast News) - EKF Diagnostics reported first-quarter trading that met expectations in an update on Wednesday, following the strong growth of its point-of-care and life sciences businesses in 2022.
Read moreEKF Diagnostics offloads ADL Health after strategic review
23rd Mar 2023 14:01
(Sharecast News) - EKF Diagnostics announced the disposal of its subsidiary, Advanced Diagnostic Laboratory (ADL Health), on Thursday.
Read moreEKF announces details of Verici Dx share distribution
20th Jun 2022 09:41
(Sharecast News) - EKF Diagnostics announced the distribution of shares in its investment in Verici Dx on Monday, to its shareholders.
Read moreEKF gets cash payment for US inventory
13th Jun 2022 09:34
(Sharecast News) - EKF Diagnostics updated the market on its strengthening cash position on Monday, having disclosed £6.7m growth in working capital in its 2021 results, "particularly as a result of additional inventory carried in the US".
Read moreEKF Diagnostics making 'good' investment progress
18th May 2022 14:57
(Sharecast News) - EKF Diagnostics said in an update on Wednesday that it has already made "good progress" with its investment plans to support growth in the new financial year.
Read moreEKF confident even as Covid-related revenues wind down
29th Mar 2022 12:53
(Sharecast News) - EKF Diagnostics reported a 25% improvement in revenue in its final results on Tuesday, to £81.8m.
Read moreEKF Diagnostics invests another £2.5m in Verici Dx
7th Mar 2022 12:07
(Sharecast News) - EKF Diagnostics announced on Monday that it had invested in more than seven million placing shares in Verici Dx, for consideration of £2.5m.
Read moreEKF ends year ahead of already-upgraded expectations
25th Jan 2022 08:55
(Sharecast News) - Point-of-care, central laboratory device and chemistry reagent company EKF Diagnostics said on Tuesday that continued strong trading would result in its performance for 2021, including adjusted EBITDA, ahead of already-upgraded market expectations.
Read moreEKF Diagnostics agrees acquisition of Texas-based ADL Health
28th Sep 2021 15:33
(Sharecast News) - Point-of-care company EKF Diagnostics has agreed to acquire the entire issued capital of Advanced Diagnostic Laboratory (ADL Health), it announced on Tuesday.
Read moreEKF Diagnostics reports continued strong trading
21st Jul 2021 14:43
(Sharecast News) - Point-of-care company EKF Diagnostics said on Wednesday that the strong trading it reported at the beginning of the year had continued through the second quarter.
Read moreEKF Diagnostics trading well as it starts looking beyond pandemic
19th May 2021 10:12
(Sharecast News) - Point-of-care company EKF Diagnostics updated the market on its trading on Wednesday, following its most successful year to date in 2020, with record turnover and profits.
Read more